Latest news with #CrucialDataSolutions
Associated Press
29-04-2025
- Business
- Associated Press
Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available as a Native macOS App
The only eClinical platform to offer native web, mobile (iOS/Android), and Mac applications, redefining the standard for modern research software. RENO, NV, UNITED STATES, April 29, 2025 / / -- Crucial Data Solutions, Inc. (CDS), the pioneer behind the all-inclusive eClinical platform TrialKit, today announced the launch of TrialKit as a native macOS app—an industry-first for clinical trial software. This milestone makes TrialKit the only platform across all key interfaces: web, mobile (iOS and Android), and now Mac. With this latest expansion, CDS reinforces its leadership in modernizing clinical research technology and delivering unmatched flexibility for sponsors and CROs worldwide. Traditional web-based solutions have long been constrained by the limitations of browser-based technology. TrialKit's availability as a native Mac app, alongside its mobile counterparts, unlocks more powerful functionality, enhanced security, and a superior user experience, enabling research professionals to build, manage, and review studies with unprecedented speed and efficiency. For Mac devotees and serious study builders alike, this means a platform that works how they work, where they work. 'At Crucial Data Solutions, we're committed to challenging the status quo and providing research professionals with the tools they need to succeed in today's fast-paced, tech-driven environment,' said Jim Bob Ward, CEO of Crucial Data Solutions. 'Bringing TrialKit to Mac was the natural next step in our journey to make clinical trial technology more accessible, flexible, and capable. With native apps across web, mobile, and now Mac, we're offering an experience no other platform can match.' The introduction of TrialKit for macOS continues CDS' momentum of industry-first innovations, following its recent advances in AI-powered analytics and its groundbreaking subscription pricing model that modernized clinical trial contracting. TrialKit's full-featured macOS app supports the entire research lifecycle from study build to data capture, review, and analytics, delivering a seamless experience optimized for speed, configurability, and data integrity. Whether in the office or on the move, research teams now have the freedom to choose their preferred device without compromising capability or performance. To learn more about TrialKit and its comprehensive suite of solutions, visit About Crucial Data Solutions Founded in 2010, Crucial Data Solutions (CDS) is the provider of TrialKit, the most innovative eClinical platform on the market. Trusted by sponsors, CROs, and research institutions worldwide, TrialKit supports the end-to-end management of clinical trials and non-interventional studies. CDS is committed to making advanced data collection and management solutions accessible to all, combining affordability, scalability, and cutting-edge technology to meet the evolving needs of the life sciences industry. Carley Nolan, Director of Marketing Crucial Data Solutions +1 888-753-4777 email us here Visit us on social media: LinkedIn YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
27-03-2025
- Business
- Associated Press
Crucial Data Solutions Launches Industry-First Subscription Model to Modernize Clinical Trial Contracting and Pricing
New model empowers CROs to grow revenue, reduces costs for sponsors, and accelerates time to market 'Technology should help sponsors and CROs do more with less, not pay more to work harder.' — Jim Bob Ward, CEO RENO, NV, UNITED STATES, March 27, 2025 / / -- Crucial Data Solutions, Inc. (CDS), provider of TrialKit, the only mobile-first, AI-powered eClinical platform, today announced a bold transformation of its pricing and contracting model. With a new subscription-based model designed to lower costs, simplify workflows, and speed up study timelines, CDS is tackling one of the most entrenched inefficiencies in the life sciences industry: outdated business models and fragmented technologies. 'Technology should help sponsors and CROs do more with less, not pay more to work harder,' said Jim Bob Ward, CEO of Crucial Data Solutions. 'We believe modernization extends beyond software. It must also reshape how studies are contracted, priced, and delivered.' This announcement comes at a pivotal moment, following FDA guidance calling for modernization through decentralized trial strategies and digital health technologies (DHTs). While regulatory initiatives have ignited demand for hybrid trials, many organizations remain burdened by high-cost, piecemeal tech stacks patched together by APIs, custom integrations, and per-study contracts. CDS is responding with a unified platform and transparent pricing model that gives customers full access to all eClinical products without the added complexity. After 15 years of investment in a single-platform architecture that supports both web and native mobile environments (iOS and Android), CDS is making its full TrialKit platform—including EDC, eCOA/ePRO, eConsent, RTSM, eTMF, and AI-powered analytics—available through a monthly subscription. Pricing starts at $1,350/month for one study, scaling up to $90,000/month for unlimited studies. 'There's no need for lengthy RFIs, RFPs, or repeated contract negotiations,' said Ward. 'We build the first study with our customers, guide them through the second, and then hand over the keys. This model enables our partners to scale their operations while dramatically reducing per-study costs.' TrialKit remains the only platform that enables full customer control over study configuration via a drag-and-drop designer across both desktop and mobile, backed by integrated AI analytics and the ability to private-label and localize the experience. Used by more than 40,000 users to build over 10,000 studies, TrialKit's proven foundation makes this shift to subscription-based pricing a natural extension, and one CDS can offer while remaining profitable and debt-free. Crucial Data Solutions is publicly publishing its subscription pricing to bring full transparency to the industry. To explore pricing tiers and learn more about the model, visit About Crucial Data Solutions Founded in 2010, Crucial Data Solutions (CDS) is the provider of TrialKit, the most innovative eClinical platform on the market. Trusted by sponsors, CROs, and research institutions worldwide, TrialKit supports the end-to-end management of clinical trials and non-interventional studies. CDS is committed to making advanced data collection and management solutions accessible to all, combining affordability, scalability, and cutting-edge technology to meet the evolving needs of the life sciences industry. Carley Nolan, Director of Marketing Legal Disclaimer:
